Thomas John Charles

Track

Insider profile

Thomas John Charles's trades of Krystal Biotech, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
218.09
Quantity 21,658 +5.1%
Value US$3,723,255
Transaction date
Proposed sale
Price
50.85
Quantity 13,695
Value US$4,271,128
Transaction date
Planned sale
Price
259.07
Quantity 40,553 -5.5%
Value US$4,181,500
Transaction date
Proposed sale
Price
302.03
Quantity 642
Value US$193,903
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-26 2026-06-25
PlS Planned sale
21,658 +5.1%
218.09
US$3,723,255 		21,658 +5.1% 218.09 US$3,723,255
2026-06-25 2026-06-25
PrS Proposed sale
13,695
50.85
US$4,271,128 		13,695 50.85 US$4,271,128
2026-05-27 2026-05-26
PlS Planned sale
40,553 -5.5%
259.07
US$4,181,500 		40,553 -5.5% 259.07 US$4,181,500
2026-05-26 2026-05-26
PrS Proposed sale
642
302.03
US$193,903 		642 302.03 US$193,903